122
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study

ORCID Icon, , , ORCID Icon, &
Pages 349-358 | Published online: 16 Feb 2021

References

  • Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.005
  • Côté A, Godbout K, Boulet L-P. The Management of Severe Asthma in 2020. Biochem Pharmacol. 2020;179:114112. doi:10.1016/j.bcp.2020.114112
  • Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015;60(3):455–468. doi:10.4187/respcare.03200
  • Boulet L-P, Vervloet D, Magar Y, Foster JM. Adherence: the goal to control asthma. Clin Chest Med. 2012;33(3):405–417. doi:10.1016/j.ccm.2012.06.002
  • Adouni Lawani M, Zongo F, Breton M-C, et al. Factors associated with adherence to asthma treatment with inhaled corticosteroids: a cross-sectional exploratory study. J Asthma. 2018;55(3):318–329. doi:10.1080/02770903.2017.1326131
  • Plaza V, López-Viña A, Entrenas LM, et al. Differences in Adherence and Non-Adherence Behaviour Patterns to Inhaler Devices Between COPD and Asthma Patients. COPD. 2016;13(5):547–554. doi:10.3109/15412555.2015.1118449
  • Zhang J, Yin C, Li H, Wei W, Gong Y, Tang F. Application of Once-Monthly Self-Reported ACT Questionnaire in Management of Adherence to Inhalers in Outpatients with Asthma. Patient Prefer Adherence. 2020;14:1027–1036. doi:10.2147/PPA.S176683
  • Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6(1):91–103. doi:10.1586/ers.11.89
  • Gregoriano C, Dieterle T, Breitenstein A-L, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):237. doi:10.1186/s12931-018-0936-3
  • Global Initiative for Asthma (GINA). 2019 GINA report, global strategy for asthma management and prevention. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed June 25, 2020
  • Soledad AM, Cesáreo AR, Antonio G-O, et al. Spanish guideline on the management of asthma. J Invest Allergol Clin Immunol. 2016;26(Suppl Supl 1):1–92.S. doi:10.18176/jiaci.0065
  • National Asthma Education and Prevention Program, Third expert panel on the diagnosis and management of asthma. Bethesda (MD): National Heart, Lung, and Blood Institute (US); 2007 Aug. Available from https://www.ncbi.nlm.nih.gov/books/NBK7232/. Accessed February 3, 2021.
  • Small M, Anderson P, Vickers A, Kay S, Fermer S. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Ther. 2011;28(3):202–212. doi:10.1007/s12325-010-0108-4
  • Gálffy G, Szilasi M, Tamasi L. Effectiveness and patient satisfaction with budesonide/formoterol easyhaler® among patients with asthma or COPD switching from previous treatment: a real-world study of patient-reported outcomes. Pulm Ther. 2019;5(2):165–177. doi:10.1007/s41030-019-0097-7
  • Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8(1):26. doi:10.1186/s40413-015-0075-y
  • Giner J, Torrejón M, Ramos A, et al. Preferencias de los pacientes en la elección de dispositivos de inhalación en polvo. Arch Bronconeumol. 2004;40(3):106–109. doi:10.1016/S0300-2896(04)75484-8
  • Perpiñá Tordera M, Viejo JL, Sanchis J, et al. Satisfacción y preferencia del paciente asmático por los dispositivos de inhalación. Aplicación del FSI-10. Arch Bronconeumol. 2008;44(7):346–352. doi:10.1016/S0300-2896(08)70447-2
  • Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.1212
  • Plaza V, Giner J, Calle M, et al. Impact of patient satisfaction with his or her inhaler on adherence and asthma control. Allergy Asthma Proc. 2018;39(6):437–444. doi:10.2500/aap.2018.39.4183
  • Valero A, Ribó P, Maíz L, et al. Asthma patient satisfaction with different dry powder inhalers. Expert Rev Respir Med. 2019;13(2):133–138. doi:10.1080/17476348.2019.1567339
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi:10.1097/00005650-198601000-00007
  • Val Jiménez A, Amorós Ballestero G, Martínez Visa P, Fernández Ferré ML, León Sanromà M. [Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test]. Aten Primaria. 1992;10(5):767–770.
  • Hogan AD, Bernstein JA. GINA updated 2019: landmark changes recommended for asthma management. Ann Allergy Asthma Immunol. 2020;124(4):311–313. doi:10.1016/j.anai.2019.11.005
  • Mauer Y, Taliercio RM. Managing adult asthma: the 2019 GINA guidelines. Cleve Clin J Med. 2020;87(9):569–575. doi:10.3949/ccjm.87a.19136
  • Papi A, Blasi F, Canonica GW, Morandi L, Richeldi L, Rossi A. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma Clin Immunol. 2020;16(1):75. doi:10.1186/s13223-020-00472-8
  • Levy ML, Carroll W, Izquierdo Alonso JL, Keller C, Lavorini F, Lehtimäki L. Understanding dry powder inhalers: key technical and patient preference attributes. Adv Ther. 2019;36(10):2547–2557. doi:10.1007/s12325-019-01066-6
  • Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients‘ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358–365. doi:10.1016/j.rmed.2013.09.021
  • Plaza V, Giner J, Curto E, et al. Determinants and differences in satisfaction with the inhaler among patients with asthma or COPD. J Allergy Clin Immunol Pract. 2020;8(2):645–653. doi:10.1016/j.jaip.2019.09.020
  • Gálffy G, Mezei G, Németh G, et al. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Drugs R D. 2013;13(3):215–222. doi:10.1007/s40268-013-0027-3
  • Lavorini F. Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease. Drugs in Context. 2019;8:212596. doi:10.7573/dic.212596
  • Chrystyn H, Lavorini F. The dry powder inhaler features of the Easyhaler that benefit the management of patients. Expert Rev Respir Med. 2020;14(4):345–351. doi:10.1080/17476348.2020.1721286